Cargando…

Is COVID-19 a risk factor for progression of benign prostatic hyperplasia and exacerbation of its related symptoms?: a systematic review

BACKGROUND: To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater risks of BPH complications such as acute urinary retention. METHODS: A categorized and comprehensive search in the literat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Haghpanah, Abdolreza, Masjedi, Fatemeh, Salehipour, Mehdi, Hosseinpour, Alireza, Roozbeh, Jamshid, Dehghani, Anahita
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8129694/ https://www.ncbi.nlm.nih.gov/pubmed/34007019 http://dx.doi.org/10.1038/s41391-021-00388-3

Ejemplares similares

Reply to De Nunzio, Franco, and Lombardo
por: Haghpanah, Abdolreza, et al.
Publicado: (2021)

Retroperitoneal mass, a rare manifestation of mucinous adenocarcinoma of appendix: A case report
por: Salehipour, Mehdi, et al.
Publicado: (2022)

Sialic acid: an attractive biomarker with promising biomedical applications
por: Doostkam, Aida, et al.
Publicado: (2022)

Comparison of post-urethroplasty complication rates in pediatric cases with hypospadias using Vicryl or polydioxanone sutures
por: Shirazi, Mehdi, et al.
Publicado: (2022)

Depressive symptoms in patients diagnosed with benign prostatic hyperplasia
por: Pietrzyk, Barbara, et al.
Publicado: (2015)

Benign Prostatic Hyperplasia
Publicado: (2015)

Periodontitis Exacerbates Benign Prostatic Hyperplasia through Regulation of Oxidative Stress and Inflammation
por: Fang, Cheng, et al.
Publicado: (2021)

Multiple pyonephrotic compartments with different microorganisms and an infected “calcium milk” in a patient with bilateral obstructive uropathy: A challenging case()
por: Buchholz, Noor, et al.
Publicado: (2022)

Assessment of the utility of platelet indices to diagnose clinical benign prostatic hyperplasia in dogs
por: Hosseinpour, Hediyeh, et al.
Publicado: (2022)

The Symptoms of Benign Prostatic Hyperplasia Patients with Stromal-Dominated Hyperplasia Nodules May Be Associated with Prostate Fibrosis
por: Cao, Ying, et al.
Publicado: (2023)

Naftopidil for the treatment of urinary symptoms in patients with benign prostatic hyperplasia
por: Masumori, Naoya
Publicado: (2011)

Outcomes of Prostate Artery Embolisation in Patients with Severe Symptoms of Benign Prostate Hyperplasia
por: ABDUL RAHIM, Rohana, et al.
Publicado: (2021)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Giant benign prostatic hyperplasia: A case report
por: Aghamir, Seyed Mohammad Kazem, et al.
Publicado: (2019)

Correlation of Subjective Symptoms in Patients with Benign Prostatic Hyperplasia and Erectile Dysfunction
por: Kardasevic, Amel, et al.
Publicado: (2017)

The influence of asymptomatic inflammatory prostatitis on the onset and progression of lower urinary tract symptoms in men with histologic benign prostatic hyperplasia
por: Taoka, Rikiya, et al.
Publicado: (2017)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Anti-Proliferative Effects of HBX-5 on Progression of Benign Prostatic Hyperplasia
por: Jin, Bo-Ram, et al.
Publicado: (2018)

Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity
por: Fu, Shi, et al.
Publicado: (2017)

Eriochloa villosa Alleviates Progression of Benign Prostatic Hyperplasia in vitro and in vivo
por: Baek, Eun Bok, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Berberine ameliorates testosterone-induced benign prostate hyperplasia in rats
por: Shabani, Ehsan, et al.
Publicado: (2021)

Lower urinary tract symptoms and benign prostatic hyperplasia: From research to bedside
por: Goel, Apul
Publicado: (2019)

Ergonomics and musculoskeletal symptoms in surgeons performing endoscopic procedures for benign prostatic hyperplasia
por: Omar, Mohamed, et al.
Publicado: (2020)

The relationship of benign prostatic hyperplasia's symptoms severity with the risk of developing atrial fibrillation
por: Koçak, Ajar, et al.
Publicado: (2022)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

Association between predictors of progression of benign prostatic hyperplasia and moderate-to-severe prostatitis-like symptoms: A propensity score–matched analysis
por: Lee, Jun Ho, et al.
Publicado: (2022)

Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride
por: Khedmati, Jamaleddin, et al.
Publicado: (2021)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_h2raj6ekudmq2oss0btpthtljf